Avidence Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
Avidence Therapeutics General Information
Description
Developer of disease-modifying drugs designed to treat pain and the progression of osteoarthritis. The company's drugs slow down or stop the progression of osteoarthritis of the knee and modulate multiple signaling mechanisms in the synthesis and degradation of articular cartilage, enabling physicians to treat patients with osteoarthritis symptoms successfully and effectively.
Contact Information
Website
www.avidenceinc.comCorporate Office
- 423 West 127th Street
- Harlem Biospace
- New York, NY 10027
- United States
Corporate Office
- 423 West 127th Street
- Harlem Biospace
- New York, NY 10027
- United States
Avidence Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup |
Avidence Therapeutics Comparisons
Industry
Financing
Details
Avidence Therapeutics Competitors (7)
One of Avidence Therapeutics’s 7 competitors is Cirius Therapeutics, a Venture Capital-Backed company based in Grand Rapids, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cirius Therapeutics | Venture Capital-Backed | Grand Rapids, MI | ||||
| Biosplice Therapeutics | Private Equity-Backed | San Diego, CA | ||||
| Metacrine | Formerly VC-backed | San Diego, CA | ||||
| Cognition Therapeutics | Formerly VC-backed | New York, NY | ||||
| Iconic Therapeutics | Formerly VC-backed | South San Francisco, CA |
Avidence Therapeutics Patents
Avidence Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025255064-A1 | Microsphere-based injectable semaglutide formulation | Pending | 04-Jun-2024 | ||
| WO-2025255070-A1 | Microsphere-based injectable tirzepatide formulation | Pending | 04-Jun-2024 | ||
| WO-2025230823-A1 | Microsphere-based injectable clascoterone formulation | Pending | 29-Apr-2024 | ||
| WO-2025230821-A1 | Microsphere-based injectable finasteride formulation | Pending | 29-Apr-2024 | ||
| WO-2025207396-A1 | Microsphere-based injectable rofecoxib formulation | Pending | 27-Mar-2024 | A61K9/5031 |
Avidence Therapeutics FAQs
-
When was Avidence Therapeutics founded?
Avidence Therapeutics was founded in 2018.
-
Where is Avidence Therapeutics headquartered?
Avidence Therapeutics is headquartered in New York, NY.
-
What industry is Avidence Therapeutics in?
Avidence Therapeutics’s primary industry is Drug Discovery.
-
Is Avidence Therapeutics a private or public company?
Avidence Therapeutics is a Private company.
-
What is Avidence Therapeutics’s current revenue?
The current revenue for Avidence Therapeutics is .
-
Who are Avidence Therapeutics’s competitors?
Cirius Therapeutics, Biosplice Therapeutics, Metacrine, Cognition Therapeutics, and Iconic Therapeutics are some of the 7 competitors of Avidence Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process